


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-0.32%
+4.43%
-18.29%
-2.00%
+11.44%
DAL
Delta Air Lines
$75.37
Strengths

Earnings are forecast to grow

Trading below its fair value

Upgraded on attractively valued

Outperform the market
DAL Price Performance
$72.31 (+4.23%)
$57.74 (+30.53%)
$58.42 (+29.01%)
$61.49 (+22.57%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Earnings increase YoY

Reported a weak earnings

Has a weak balance sheet

Revenue declined YoY

Eps growth
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
DAL Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
DAL Street Sentiment is bullish and have positive views on the near-term outlook
DAL has Fair risk level
Risks Indicators

Beta greater than 1.0

Investors losing confidence

Average key support and resistance price levels
Recent Upgrades and Downgrades
STRONG BUY
Date
Action
Rating
Firm
Jan 23, 2026
Reiterate
Buy
Seaport
Jan 14, 2026
Price Target Raised
Overweight
Barclays
Dec 09, 2025
Initiate
Outperform
BMO Capital
Dec 09, 2025
Upgrade
Hold
United Chases Market Share With Service
Dec 05, 2025
Initiate
Buy
Citigroup
What is DAL current stock price?
What are DAL stock strengths?
What is DAL Risk Level?
What is DAL market cap and volume?
What is DAL current Stock IQ?
Should I buy DAL stock right now?
Is DAL a Strong Buy right now?
What does a 'Strong Buy' rating mean for DAL?
What does a 'Strong Sell' rating mean for DAL?
What factors influence DAL's Stock IQ?
Join over 5,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-0.32%
+4.43%
-18.29%
-2.00%
+11.44%
DAL
Delta Air Lines
Current Price
$75.37

DAL Price Performance
$72.31 (+4.23%)
$57.74 (+30.53%)
$58.42 (+29.01%)
$61.49 (+22.57%)
DAL Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Earnings increase YoY

Reported a weak earnings

Has a weak balance sheet

Revenue declined YoY

Eps growth
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
DAL Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
DAL Street Sentiment is bullish and have positive views on the near-term outlook
DAL has Fair risk level
Risks Indicators

Beta greater than 1.0

Investors losing confidence

Average key support and resistance price levels
Overall Wall Street Rating
STRONG BUY
Jan 23, 2026
Reiterate
Buy
Seaport
Jan 14, 2026
Price Target Raised
Overweight
Barclays
Dec 09, 2025
Initiate
Outperform
BMO Capital
Dec 09, 2025
Upgrade
Hold
United Chases Market Share With Service
Dec 05, 2025
Initiate
Buy
Citigroup
DAL Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Trading below its fair value

Upgraded on attractively valued

Outperform the market
DAL Latest Analysis
Where is Delta Air Lines (DAL) Headed According to the Street?. Delta Air Lines Inc. (NYSE:DAL) is one of the most undervalued travel stocks to buy according to hedge funds. Reuters reported on January 27 that Delta Air Lines Inc. (NYSE:DAL) announced plans to purchase 31 Airbus widebody jets supporting its long-term goal to modernize its international fleet and support future growth with a focus on [….]
Fri Feb 6, 2026
Delta Air Lines Inc. (DAL) Is a Trending Stock: Facts to Know Before Betting on It. Zacks.com users have recently been watching Delta (DAL) quite a bit. Thus it is worth knowing the facts that could determine the stocks prospects.
Thu Feb 5, 2026
Delta Air Lines declares $0.1875 dividend.
Wed Feb 4, 2026
$100 Invested In Delta Air Lines 15 Years Ago Would Be Worth This Much Today. Delta Air Lines (NYSE:DAL) has outperformed the market over the past 15 years by 1.2% on an annualized basis producing an average annual return of 12.83%. Currently Delta Air Lines has a market capitalization of $46.66 billion.
Wed Feb 4, 2026
ANELLO Photonics and Delta Black Aerospace Announce Partnership to Deliver Assured Navigation for Uncrewed Aircraft in GPS-Denied Environments. The collaboration centers on the integration and evaluation of ANELLO'.s optical inertial navigation systems based on its silicon photonic optical gyroscope (SiPhOG) technology with Delta Black Aerospace'.s uncrewed aircraft platforms. The effort is aimed at delivering assured position navigation and timing (PNT) performance in environments where G
Tue Feb 3, 2026
BofA Sees Conservative 2026 Guidance for Delta (DAL). Delta Air Lines Inc. (NYSE:DAL) ranks among the stocks with the lowest forward PE ratios. On January 16 BofA Securities maintained its Buy rating on Delta Air Lines Inc. (NYSE:DAL) with an $80 price target. The firm believes Delta has taken a cautious stance when it comes to its 2026 earnings forecast projecting EPS of [….]
Tue Feb 3, 2026
FDA Strikes Off European Biotech Pharmings Immune Deficiency Drug For Expanded Use In Pediatric Patients. The United States Food and Drug Administration (FDA) on Friday issued a Complete Response Letter (CRL) to ) supplemental New Drug Application (sNDA) for Joenja (leniolisib) for children aged 4 to 11 years with activated phosphoinositide 3-kinase delta syndrome (APDS) a .APDS causes recurrent respiratory infections chronic viral infections and immune dysfunction including lymphoproliferation
Mon Feb 2, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.